Author:
Papp Zoltán,Édes István,Fruhwald Sonja,De Hert Stefan G.,Salmenperä Markku,Leppikangas Heli,Mebazaa Alexandre,Landoni Giovanni,Grossini Elena,Caimmi Philippe,Morelli Andrea,Guarracino Fabio,Schwinger Robert H.G.,Meyer Sven,Algotsson Lars,Wikström Bernt Gerhard,Jörgensen Kirsten,Filippatos Gerasimos,Parissis John T.,González Martín J. García,Parkhomenko Alexander,Yilmaz Mehmet Birhan,Kivikko Matti,Pollesello Piero,Follath Ferenc
Subject
Cardiology and Cardiovascular Medicine
Reference99 articles.
1. CK-1827452, a sarcomere-directed cardiac myosin activator for acute and chronic heart disease;Solaro;IDrugs,2009
2. Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts;Sakata;Am J Physiol Heart Circ Physiol,2007
3. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial;Follath;Lancet,2002
4. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN);Moiseyev;Eur Heart J,2002
5. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial;Mebazaa;Jama,2007
Cited by
260 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献